trending Market Intelligence /marketintelligence/en/news-insights/trending/nrvbt8yjya8oroy1dezefq2 content esgSubNav
In This List

Coloplast fiscal Q1 profit down 1% YOY

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Coloplast fiscal Q1 profit down 1% YOY

Coloplast A/S reported a slight drop in its fiscal first-quarter net profit.

The Danish healthcare equipment manufacturer booked 940 million Danish kroner, or 4.42 kroner per share, in net profit for the three months ended Dec. 31, 2017. This compares to 946 million kroner, or 4.46 kroner per share, in the comparable quarter of the last fiscal year.

The S&P Capital IQ normalized EPS consensus estimate for the fiscal first quarter was 4.55 Danish kroner.

Coloplast booked fiscal first-quarter revenue of 3.96 billion kroner, up 5% year over year.

In other news, the company's board approved a new 1 billion kroner share buyback program.

Coloplast also said it acquired France-based Lilial, a distributor of catheters and ostomy supplies, for €35.5 million in early January.

As of Jan. 31, US$1 was equivalent to 5.98 Danish kroner.